FDA, EMA tout benefits of parallel scientific advice program
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsGlobalHealth Authority meeting and communication strategyPharmaceuticalsProduct LifecycleProject managementResearch, Design and Development